PLoS ONE (Jan 2019)

Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.

  • Bojan Ljepoja,
  • Christoph Schreiber,
  • Florian A Gegenfurtner,
  • Jonathan García-Roman,
  • Bianca Köhler,
  • Stefan Zahler,
  • Joachim O Rädler,
  • Ernst Wagner,
  • Andreas Roidl

DOI
https://doi.org/10.1371/journal.pone.0224314
Journal volume & issue
Vol. 14, no. 11
p. e0224314

Abstract

Read online

Cancer progression and metastases are frequently related to changes of cell motility. Amongst others, the microRNA-200c (miR-200c) was shown to maintain the epithelial state of cells and to hamper migration. Here, we describe two miR-200c inducible breast cancer cell lines, derived from miR-200c knock-out MCF7 cells as well as from the miR-200c-negative MDA-MB-231 cells and report on the emerging phenotypic effects after miR-200s induction. The induction of miR-200c expression seems to effect a rapid reduction of cell motility, as determined by 1D microlane migration assays. Sustained expression of miR200c leads to a changed morphology and reveals a novel mechanism by which miR-200c interferes with cytoskeletal components. We find that filamin A expression is attenuated by miRNA-200c induced downregulation of the transcription factors c-Jun and MRTF/SRF. This potentially novel pathway that is independent of the prominent ZEB axis could lead to a broader understanding of the role that miR200c plays in cancer metastasis.